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Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-06117-y, published online 27 July 2017
The PDF version of this Article was inadvertently replaced after publication. This has now been corrected; the 
HTML version of the paper was correct from the time of publication.
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